JeffreyRothmanMD
Endocrinology • Staten Island, NYDiabetes, Osteoporosis & Bone Metabolism Medicine, Parathyroid, Thyroid
Clinical Associate Professor of Medicine, SUNY Downstate Associate Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Dr. Rothman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1460 Victory Blvd
Staten Island, NY 10301Phone+1 718-442-0300
Education & Training
University of Pennsylvania Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 1975 - 1977- University of Pennsylvania Health SystemResidency, Internal Medicine, 1970 - 1973
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1970
Certifications & Licensure
NY State Medical License 1977 - 2025
PA State Medical License 1971 - 1988- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus Start of enrollment: 2010 May 01
- A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
Publications & Presentations
PubMed
- 2 citationsLong-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.Nelson B Watts, John P Bilezikian, Henry G Bone, Bart L Clarke, Douglas Denham
Journal of the Endocrine Society. 2023-03-06 - 40 citationsSafety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.Michael Mannstadt, Bart L. Clarke, John P. Bilezikian, Henry G. Bone, Douglas Denham
The Journal of Clinical Endocrinology and Metabolism. 2019-11-01 - 14 citationsSafety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-μg or 50-μg Daily Doses.John P. Bilezikian, Bart L. Clarke, Michael Mannstadt, Jeffrey Rothman, Tamara Vokes
Clinical Therapeutics. 2017-10-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
